These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37311879)

  • 1. Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy.
    Hammer SS; Dorweiler TF; McFarland D; Adu-Agyeiwaah Y; Mast N; El-Darzi N; Fortmann SD; Nooti S; Agrawal DK; Pikuleva IA; Abela GS; Grant MB; Busik JV
    Diabetologia; 2023 Sep; 66(9):1705-1718. PubMed ID: 37311879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
    Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
    Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
    Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
    Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy.
    Dharmarajan S; Carrillo C; Qi Z; Wilson JM; Baucum AJ; Sorenson CM; Sheibani N; Belecky-Adams TL
    Diabetologia; 2023 Nov; 66(11):2170-2185. PubMed ID: 37670018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.
    Jenkins AJ; Grant MB; Busik JV
    Diabetologia; 2022 Apr; 65(4):587-603. PubMed ID: 35149880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of X-box binding protein 1 in Müller cells augments retinal inflammation in a mouse model of diabetes.
    Yang J; Chen C; McLaughlin T; Wang Y; Le YZ; Wang JJ; Zhang SX
    Diabetologia; 2019 Mar; 62(3):531-543. PubMed ID: 30612139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.
    Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A
    Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor.
    Hammer SS; Beli E; Kady N; Wang Q; Wood K; Lydic TA; Malek G; Saban DR; Wang XX; Hazra S; Levi M; Busik JV; Grant MB
    EBioMedicine; 2017 Aug; 22():181-190. PubMed ID: 28774737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking Hemopexin With Specific Antibodies: A New Strategy for Treating Diabetic Retinopathy.
    Bogdanov P; Duarri A; Sabater D; Salas A; Isla-Magrané H; Ramos H; Huerta J; Valeri M; García-Arumí J; Simó R; Hernández C
    Diabetes; 2023 Dec; 72(12):1841-1852. PubMed ID: 37722135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction.
    Hammer SS; Vieira CP; McFarland D; Sandler M; Levitsky Y; Dorweiler TF; Lydic TA; Asare-Bediako B; Adu-Agyeiwaah Y; Sielski MS; Dupont M; Longhini AL; Li Calzi S; Chakraborty D; Seigel GM; Proshlyakov DA; Grant MB; Busik JV
    Diabetologia; 2021 Jul; 64(7):1674-1689. PubMed ID: 33770194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
    Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
    Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line.
    El-Remessy AB; Rajesh M; Mukhopadhyay P; Horváth B; Patel V; Al-Gayyar MM; Pillai BA; Pacher P
    Diabetologia; 2011 Jun; 54(6):1567-78. PubMed ID: 21373835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
    J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
    Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
    Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia Induces Mitochondrial Reactive Oxygen Species Production Through Increased Fatty Acid Oxidation and Promotes Retinal Vascular Permeability in Diabetic Mice.
    Yoshinaga A; Kajihara N; Kukidome D; Motoshima H; Matsumura T; Nishikawa T; Araki E
    Antioxid Redox Signal; 2021 Jun; 34(16):1245-1259. PubMed ID: 32757614
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
    Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
    Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia-induced effects on glycocalyx components in the retina.
    Kaur G; Rogers J; Rashdan NA; Cruz-Topete D; Pattillo CB; Hartson SD; Harris NR
    Exp Eye Res; 2021 Dec; 213():108846. PubMed ID: 34801534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.